Fusion proteins comprising the tumor rejection antigens NY-ESO-1 and LAGE-1

Details for Australian Patent Application No. 2008206463 (hide)

Owner GlaxoSmithKline Biologicals sa

Inventors Rioux, Clement; Blais, Normand; Boyer, Martine; Palmantier, Remi M.; Martin, Denis; Brichard, Vincent; Louahed, Jamila

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008206463

PCT Pub. Number WO2008/089074

Priority 60/914,848 30.04.07 US; 0700759.4 15.01.07 GB; 60/914,925 30.04.07 US; 0701262.8 21.05.07 GB

Filing date 11 January 2008

Wipo publication date 24 July 2008

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/089074 Priority application(s): WO2008/089074

6 August 2009 Amendment Made

  The nature of the amendment is: Amend the priority details from 0701262.8 to 0709707.4

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008206464-Spinal stabilization system

2008206462-Combinatorial libraries of conformationally constrained polypeptide sequences